BioPharma Credit PLC
BOPCF
$0.96
$0.011.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 4.35% | 4.35% | 5.86% | 5.86% | 23.88% |
| Total Revenue | 4.35% | 4.35% | 5.86% | 5.86% | 23.88% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 4.35% | 4.35% | 5.86% | 5.86% | 23.88% |
| SG&A Expenses | -17.63% | -17.63% | 54.41% | 54.41% | 4.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -126.83% | -126.83% | -239.33% | -239.33% | 2,150.00% |
| Total Operating Expenses | -17.85% | -17.85% | 50.83% | 50.83% | 4.33% |
| Operating Income | 13.41% | 13.41% | 1.28% | 1.28% | 34.14% |
| Income Before Tax | 13.44% | 13.44% | 1.32% | 1.32% | 34.16% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 13.44% | 13.44% | 1.32% | 1.32% | 34.16% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 13.44% | 13.44% | 1.32% | 1.32% | 34.16% |
| EBIT | 13.41% | 13.41% | 1.28% | 1.28% | 34.14% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 20.48% | 20.48% | 9.72% | 9.72% | 45.83% |
| Normalized Basic EPS | 20.61% | 20.61% | 10.00% | 10.00% | 45.56% |
| EPS Diluted | 20.48% | 20.48% | 9.72% | 9.72% | 45.83% |
| Normalized Diluted EPS | 20.61% | 20.61% | 10.00% | 10.00% | 45.56% |
| Average Basic Shares Outstanding | -5.80% | -5.80% | -7.70% | -7.70% | -7.99% |
| Average Diluted Shares Outstanding | -5.80% | -5.80% | -7.70% | -7.70% | -7.99% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 1.15% | 1.15% | -0.57% | -0.57% | -0.47% |